The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial
- PMID: 38423623
- PMCID: PMC10918318
- DOI: 10.1183/13993003.01001-2023
The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial
Abstract
Background: Our objective was to investigate the effect of a day-long exposure to high altitude on peak exercise capacity and safety in stable patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).
Methods: In a randomised controlled crossover trial, stable patients with PAH or distal CTEPH without resting hypoxaemia at low altitude performed two incremental exercise tests to exhaustion: one after 3-5 h at high altitude (2500 m) and one at low altitude (470 m).
Results: In 27 patients with PAH/CTEPH (44% females, mean±sd age 62±14 years), maximal work rate was 110±64 W at 2500 m and 123±64 W at 470 m (-11%, 95% CI -16- -11%; p<0.001). Oxygen saturation measured by pulse oximetry and arterial oxygen tension at end-exercise were 83±6% versus 91±6% and 6.1±1.9 versus 8.6±1.9 kPa (-8% and -29%; both p<0.001) at 2500 versus 470 m, respectively. Maximal oxygen uptake was 17.8±7.5 L·min-1·kg-1 at high altitude versus 20±7.4 L·min-1·kg-1 at low altitude (-11%; p<0.001). At end-exercise, the ventilatory equivalent for carbon dioxide was 43±9 at 2500 m versus 39±9 at 470 m (9%, 95% CI 2-6%; p=0.002). No adverse events occurred during or after exercise.
Conclusions: Among predominantly low-risk patients with stable PAH/CTEPH, cycling exercise during the first day at 2500 m was well tolerated, but peak exercise capacity, blood oxygenation and ventilatory efficiency were lower compared with 470 m.
Copyright ©The authors 2024.
Conflict of interest statement
Conflict of interest: None of the authors have any conflicts of interest in relation to this manuscript.
Figures


Comment in
-
High altitude travelling with pulmonary arterial hypertension.Eur Respir J. 2024 Mar 7;63(3):2400111. doi: 10.1183/13993003.00111-2024. Print 2024 Mar. Eur Respir J. 2024. PMID: 38453244 No abstract available.
Similar articles
-
Differences in Exercise Capacity, Ventilatory Efficiency, and Gas Exchange between Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Residing at High Altitude.Rev Cardiovasc Med. 2024 Jul 4;25(7):247. doi: 10.31083/j.rcm2507247. eCollection 2024 Jul. Rev Cardiovasc Med. 2024. PMID: 39139420 Free PMC article.
-
Effect of a day-trip to altitude (2500 m) on exercise performance in pulmonary hypertension: randomised crossover trial.ERJ Open Res. 2021 Oct 11;7(4):00314-2021. doi: 10.1183/23120541.00314-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34651040 Free PMC article.
-
Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.Eur Respir J. 2019 Aug 1;54(2):1900276. doi: 10.1183/13993003.002762019. Print 2019 Aug. Eur Respir J. 2019. PMID: 31073087 Clinical Trial.
-
Effectiveness and safety of exercise training and rehabilitation in chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.Ann Palliat Med. 2021 Jul;10(7):8134-8146. doi: 10.21037/apm-21-1758. Ann Palliat Med. 2021. PMID: 34353098
-
Comparative Effectiveness of Exercise Training for Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2021 Jun 17;8:664984. doi: 10.3389/fcvm.2021.664984. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34222365 Free PMC article.
Cited by
-
Long-term maternal and fetal outcomes of pulmonary hypertension in pregnancy in the southwest plateau area of China: a retrospective study.BMC Pulm Med. 2025 May 29;25(1):272. doi: 10.1186/s12890-025-03729-3. BMC Pulm Med. 2025. PMID: 40442624 Free PMC article.
-
PVRI International Conference 2025: Embracing Heterogeneity.Pulm Circ. 2025 May 1;15(2):e70093. doi: 10.1002/pul2.70093. eCollection 2025 Apr. Pulm Circ. 2025. PMID: 40321896 Free PMC article. No abstract available.
-
Peak Eccentric Cycling Exercise and Cardiorespiratory Responses to Normobaric Hypoxia Versus Normobaric Normoxia in Healthy Adults: A Randomized, Controlled Crossover Trial.J Clin Med. 2025 Feb 11;14(4):1151. doi: 10.3390/jcm14041151. J Clin Med. 2025. PMID: 40004681 Free PMC article.
-
Hypertension Prevalence Among People Lifted Out of Poverty in China in 2018-2023: Retrospective Spatiotemporal Analysis.JMIR Public Health Surveill. 2025 Aug 19;11:e66501. doi: 10.2196/66501. JMIR Public Health Surveill. 2025. PMID: 40829144 Free PMC article.
-
Differences in Exercise Capacity, Ventilatory Efficiency, and Gas Exchange between Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Residing at High Altitude.Rev Cardiovasc Med. 2024 Jul 4;25(7):247. doi: 10.31083/j.rcm2507247. eCollection 2024 Jul. Rev Cardiovasc Med. 2024. PMID: 39139420 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous